CA2866448A1 - Methods of inhibiting gonad maturation - Google Patents

Methods of inhibiting gonad maturation Download PDF

Info

Publication number
CA2866448A1
CA2866448A1 CA2866448A CA2866448A CA2866448A1 CA 2866448 A1 CA2866448 A1 CA 2866448A1 CA 2866448 A CA2866448 A CA 2866448A CA 2866448 A CA2866448 A CA 2866448A CA 2866448 A1 CA2866448 A1 CA 2866448A1
Authority
CA
Canada
Prior art keywords
fish
protein
gonads
iam
target protein
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA2866448A
Other languages
English (en)
French (fr)
Inventor
Igor BABIAK
Reid HOLE
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nord University
Original Assignee
NORDLAND, University of
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by NORDLAND, University of filed Critical NORDLAND, University of
Publication of CA2866448A1 publication Critical patent/CA2866448A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
    • A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
    • A61K47/646—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent the entire peptide or protein drug conjugate elicits an immune response, e.g. conjugate vaccines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031—Proteins

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Virology (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
CA2866448A 2012-03-09 2013-03-11 Methods of inhibiting gonad maturation Abandoned CA2866448A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB1204280.0 2012-03-09
GB201204280A GB201204280D0 (en) 2012-03-09 2012-03-09 Methods
PCT/GB2013/050592 WO2013132274A2 (en) 2012-03-09 2013-03-11 Methods of inhibiting gonad maturation

Publications (1)

Publication Number Publication Date
CA2866448A1 true CA2866448A1 (en) 2013-09-12

Family

ID=46026353

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2866448A Abandoned CA2866448A1 (en) 2012-03-09 2013-03-11 Methods of inhibiting gonad maturation

Country Status (8)

Country Link
US (2) US9931385B2 (https=)
EP (2) EP2822580B1 (https=)
JP (1) JP2015510878A (https=)
KR (1) KR20150010707A (https=)
CA (1) CA2866448A1 (https=)
CL (1) CL2014002387A1 (https=)
GB (1) GB201204280D0 (https=)
WO (1) WO2013132274A2 (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201204280D0 (en) 2012-03-09 2012-04-25 Univ Nordland Methods
CN112625118B (zh) * 2020-11-26 2022-05-24 广东海洋大学 一种金钱鱼促生殖细胞成熟基因igf3及其应用
CN115281151B (zh) * 2022-07-27 2023-07-18 广东省科学院动物研究所 miR-34b/c基因抑制剂在调控施氏鲟早期性别分化中的应用

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1979000133A1 (en) * 1977-09-06 1979-03-22 Nat Res Dev Improvements in or relating to fish farming
US4798885A (en) * 1986-02-07 1989-01-17 Genentech, Inc. Compositions of hormonally active human and porcine inhibin containing an α chain and 62 chain
NZ220932A (en) * 1986-07-03 1990-05-28 Victoria State Composition comprising an antigenic substance, such as lhrh, conjugated to at least two different carriers and method of immunological castration and spaying
US4996297A (en) * 1987-10-07 1991-02-26 Zonagen, Inc. Recombinantly expressed rabbit zona pellucida polypeptides
US6790457B1 (en) * 1998-12-22 2004-09-14 Dalhousie University Compositions and methods for reducing or preventing fertilization in fish and birds
EP1140151A2 (en) 1998-12-22 2001-10-10 Dalhousie University Compositions and methods for reducing or preventing fertilization in fish and birds
US7194978B2 (en) 2003-08-22 2007-03-27 University Of Maryland Biotechnology Institute Inducing sterility in fish by disrupting the development of the GnRH system
DK179025B1 (da) * 2005-09-16 2017-08-28 Intervet Int Bv Fiskevaccine
WO2012106026A2 (en) 2011-02-01 2012-08-09 Purdue Research Foundation Efficient sterilization of fish by disruption of germ cell development
GB201204280D0 (en) 2012-03-09 2012-04-25 Univ Nordland Methods

Also Published As

Publication number Publication date
JP2015510878A (ja) 2015-04-13
US20190046618A1 (en) 2019-02-14
US9931385B2 (en) 2018-04-03
EP3466441A3 (en) 2019-06-19
WO2013132274A3 (en) 2013-11-14
WO2013132274A2 (en) 2013-09-12
EP2822580B1 (en) 2019-01-02
GB201204280D0 (en) 2012-04-25
EP2822580A2 (en) 2015-01-14
US20150104474A1 (en) 2015-04-16
EP3466441A2 (en) 2019-04-10
CL2014002387A1 (es) 2015-07-10
KR20150010707A (ko) 2015-01-28

Similar Documents

Publication Publication Date Title
US10136621B2 (en) Method of producing infertile fish and egg-producing aquatic animals and of delivering compounds into eggs and embryos
Golpour et al. Induced sterility in fish and its potential and challenges for aquaculture and germ cell transplantation technology: a review
Bar et al. Assessment of yellowtail kingfish (Seriola lalandi) as a surrogate host for the production of southern bluefin tuna (Thunnus maccoyii) seed via spermatogonial germ cell transplantation
US20190046618A1 (en) Methods of inhibiting gonad maturation
KR19990022555A (ko) 인히빈 조성물 및 증식 성능 개선 방법
Presslauer et al. Induced autoimmunity against gonadal proteins affects gonadal development in juvenile zebrafish
Zhou et al. Examination of the role of the forkhead box L2 (Foxl2) in gonadal and embryonic development in the boring giant clam Tridacna crocea
Wu et al. The roles of two myostatins and immune effects after inhibition in Qi river crucian carp (Carassius auratus)
Sun et al. Sexual dimorphic expression of dnd in germ cells during sex reversal and its requirement for primordial germ cell survival in protogynous hermaphroditic grouper
Buwono et al. Reproduction performance of transgenic mutiara catfish (G1) comprising the growth hormone gene
Corripio-Miyar et al. RAG-1 and IgM genes, markers for early development of the immune system in the gadoid haddock, Melanogrammus aeglefinus, L.
Debnanth A review on the physiology of insulin-like growth factor-I (IGF-I) peptide in bony fishes and its phylogenetic correlation in 30 different taxa of 14 families of teleosts
Chen et al. Transfer of a foreign gene to Japanese abalone (Haliotis diversicolor supertexta) by direct testis-injection
Parenrengi et al. Enhancement of tiger shrimp Penaeus monodon resistance to white spot syndrome virus by overexpression of antiviral gene
Delgado et al. Temporal and spatial expression pattern of the myostatin gene during larval and juvenile stages of the Chilean flounder (Paralichthys adspersus)
Nakamura et al. Sex differentiation, sex change, and sex control in groupers
Yang et al. Expression of perforin gene for early development of nephrons in olive flounder (Paralichthys olivaceus)
Martinez-Lopez et al. Increasing versatility of the DNA vaccines through modification of the subcellular location of plasmid-encoded antigen expression in the in vivo transfected cells
Fang et al. A novel DDX5 gene in the freshwater crayfish Cherax quadricarinatus is highly expressed during ontogenesis and spermatogenesis
Peng et al. Production and purification of recombinant somatolactin and its effects on insulin-like growth factors gene expression in tilapia hepatocytes
Xu Developing technologies to produce reproductively sterile finfish and oysters, and characterizing changes of gene expression in the pituitary of sterile fish by single-cell RNA sequencing
Ye Alternative approaches for repressible transgenic sterilization of channel catfish (Ictalurus punctatus)
Valero Immune response in fish gonad upon nodavirus infection and vaccines development
Valero Cuesta Immune response in fish gonad upon nodavirus infection and vaccines development= Implicación de la respuesta inmunitaria de la gónada de peces durante una infección con nodavirus y desarrollo de vacunas
Tesfamichael Expression and functional characterization of zebrafish gonadal soma-derived growth factor

Legal Events

Date Code Title Description
EEER Examination request

Effective date: 20180307

FZDE Dead

Effective date: 20200831